LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 100 filers reported holding LEXICON PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $89,304 | +89.8% | 81,930 | +298.7% | 0.00% | – |
| Q2 2023 | $47,055 | -55.5% | 20,548 | -52.8% | 0.00% | – |
| Q1 2023 | $105,761 | +219.5% | 43,523 | +151.1% | 0.00% | – |
| Q4 2022 | $33,102 | -60.1% | 17,331 | -49.8% | 0.00% | – |
| Q3 2022 | $83,000 | +102.4% | 34,541 | +75.1% | 0.00% | – |
| Q1 2022 | $41,000 | -78.5% | 19,723 | -59.3% | 0.00% | – |
| Q4 2021 | $191,000 | -27.7% | 48,467 | -11.6% | 0.00% | – |
| Q3 2021 | $264,000 | +60.0% | 54,820 | +52.7% | 0.00% | – |
| Q2 2021 | $165,000 | +24.1% | 35,911 | +58.4% | 0.00% | – |
| Q1 2021 | $133,000 | +682.4% | 22,676 | +88.8% | 0.00% | – |
| Q3 2020 | $17,000 | -52.8% | 12,011 | -33.8% | 0.00% | – |
| Q2 2020 | $36,000 | -37.9% | 18,147 | +29.7% | 0.00% | – |
| Q4 2019 | $58,000 | -68.5% | 13,991 | -77.1% | 0.00% | – |
| Q3 2019 | $184,000 | – | 61,166 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 71,178,364 | $280,443,000 | 7.61% |
| BVF INC/IL | 14,360,000 | $56,578,000 | 2.05% |
| Integral Health Asset Management, LLC | 200,000 | $788,000 | 0.22% |
| Eversept Partners, LP | 797,694 | $3,142,914 | 0.20% |
| NEA Management Company, LLC | 2,382,286 | $9,386,000 | 0.19% |
| PINNACLE ASSOCIATES LTD | 2,127,662 | $8,383,000 | 0.14% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $141,000 | 0.06% |
| Virtus ETF Advisers LLC | 41,584 | $164,000 | 0.06% |
| Pegasus Asset Management, Inc. | 10,000 | $39,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 31,562 | $124,000 | 0.02% |